Language as an Eligibility Criterion in Pediatric Study Protocols Conducted in Europe (2007–2024) Reported in the ClinicalTrials.gov Database

Begonya Nafria, Alexander Perera, Segolene Gaillard, Martine Dehlinger-Kremer, Pamela Dicks, Ricardo M. Fernandes, Gilles Vassal, Pirkko Lepola, Gunter F. Egger, Lucy Bray, Barbara E. Bierer, Bob Phillips

Open source

DOI
10.1007/s40290-026-00613-1
Published
2026-06-22
Container
Pharmaceutical Medicine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40290-026-00613-1,
  title = {Language as an Eligibility Criterion in Pediatric Study Protocols Conducted in Europe (2007–2024) Reported in the ClinicalTrials.gov Database},
  author = {Begonya Nafria and Alexander Perera and Segolene Gaillard and Martine Dehlinger-Kremer and Pamela Dicks and Ricardo M. Fernandes and Gilles Vassal and Pirkko Lepola and Gunter F. Egger and Lucy Bray and Barbara E. Bierer and Bob Phillips},
  year = {2026},
  journal = {Pharmaceutical Medicine},
  doi = {10.1007/s40290-026-00613-1},
  url = {https://doi.org/10.1007/s40290-026-00613-1}
}

RIS

TY  - JOUR
TI  - Language as an Eligibility Criterion in Pediatric Study Protocols Conducted in Europe (2007–2024) Reported in the ClinicalTrials.gov Database
AU  - Begonya Nafria
AU  - Alexander Perera
AU  - Segolene Gaillard
AU  - Martine Dehlinger-Kremer
AU  - Pamela Dicks
AU  - Ricardo M. Fernandes
AU  - Gilles Vassal
AU  - Pirkko Lepola
AU  - Gunter F. Egger
AU  - Lucy Bray
AU  - Barbara E. Bierer
AU  - Bob Phillips
PY  - 2026
JO  - Pharmaceutical Medicine
DO  - 10.1007/s40290-026-00613-1
UR  - https://doi.org/10.1007/s40290-026-00613-1
ER  - 

APA

Nafria, B., Perera, A., Gaillard, S., Dehlinger-Kremer, M., Dicks, P., Fernandes, R. M., Vassal, G., Lepola, P., Egger, G. F., Bray, L., Bierer, B. E., & Phillips, B. (2026). Language as an Eligibility Criterion in Pediatric Study Protocols Conducted in Europe (2007–2024) Reported in the ClinicalTrials.gov Database. Pharmaceutical Medicine. https://doi.org/10.1007/s40290-026-00613-1

Source records